Drug shortages aren’t accidents-they’re the result of a fragile, cost-optimized supply chain. Building real resilience means diversifying suppliers, stockpiling critical drugs, using AI to predict disruptions, and securing digital infrastructure. The fix isn’t expensive-it’s necessary.
